Metabolic Syndrome and Leptin Level Associated With Fructose Consumption in Spain

Sponsor
Hospital Mateo Orfila (Other)
Overall Status
Completed
CT.gov ID
NCT00651001
Collaborator
(none)
800
1
12
66.7

Study Details

Study Description

Brief Summary

A Food Frequency Questionnaire (FFQ), will be provided to 800 adults to assess overall fructose intake and this will be related to a number of features related to the metabolic syndrome, including serum leptin, characteristic features of metabolic syndrome (body mass index, waist circumference, plasma lipids, blood pressure, HOMA index,fasting glucose and fasting insulin levels) and other as: CRP, fibrinogen, homocysteine and uric acid.

Condition or Disease Intervention/Treatment Phase

    Study Design

    Study Type:
    Observational
    Anticipated Enrollment :
    800 participants
    Observational Model:
    Ecologic or Community
    Time Perspective:
    Cross-Sectional
    Official Title:
    Prevalence of Cardiovascular Risk Factors in Minorca - Spain
    Study Start Date :
    Jun 1, 2008
    Actual Primary Completion Date :
    Jan 1, 2009
    Study Completion Date :
    Jun 1, 2009

    Outcome Measures

    Primary Outcome Measures

    1. Serum leptin levels as it relates to fructose intake [Epidemiological association]

    Secondary Outcome Measures

    1. Relationship of metabolic syndrome features with fructose intake. This includes measuring all 5 components of metabolic syndrome, assessing insulin resistance by HOMA, and measuring some markers of inflammation (CRP, fibrinogen, homocysteine) [Epidemiological]

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years to 70 Years
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    Yes
    Inclusion Criteria:
    • Adults, 18-70 years of age
    Exclusion Criteria:
    • Diabetes

    • Kidney Failure

    • Heart Failure

    • Cancer

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Renal Unit of Mateo Orfila Hospital, Balearic Islands - Spain Menorca Balearic Islands Spain 07703

    Sponsors and Collaborators

    • Hospital Mateo Orfila

    Investigators

    None specified.

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    , ,
    ClinicalTrials.gov Identifier:
    NCT00651001
    Other Study ID Numbers:
    • IbSalut-M-002
    First Posted:
    Apr 2, 2008
    Last Update Posted:
    Aug 6, 2009
    Last Verified:
    Aug 1, 2009

    Study Results

    No Results Posted as of Aug 6, 2009